⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026

NSE

Alkem Laboratories LimitedALKEM

ALKEM₹5,348 0.92% today
Nifty Midcap 150

Alkem Laboratories is a leading branded-generics company in India.

Key productsAcute & chronic branded generics (Clavam, Pan-D), US generics.
GeographyIndia and the US.
CompetitorsSun Pharma, Mankind, Cipla.

AI-generated overview — verify before relying on it.

Net institutional flow

+103.5 Cr

Institutional buyers

16 in / 1 out

High-impact filings

0 · tilt Neutral

Next corporate action

Competitive landscape — the read

vs mapped peers
Institutional money is backing CIPLA hardest (+1,527.1 Cr net). ALKEM ranks #3 of 9 on flow (net buying +103.5 Cr). Filing momentum favours SUNPHARMA (+2). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1CIPLA+1,527.1 Cr39+1+1034
2MANKIND+445.9 Cr38
3ALKEMThis+103.5 Cr33-26
4DRREDDY+0 Cr4+1432
5SUNPHARMA+0 Cr6+2+929
6TORNTPHARM+0 Cr2
7LUPIN+0 Cr4
8ZYDUSLIFE+0 Cr1
9AUROPHARMA+0 Cr2

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — ALKEM day by day

  1. 2026-06-15FilingAlkem Laboratories Limited has informed the Exchange about Schedule of meetInvestor Call
  2. 2026-06-10FilingAlkem Laboratories Limited has informed the Exchange about Schedule of meetInvestor Call
  3. 2026-06-02BulkBUY · ₹469.8 CrICICI PRUDENTIAL MUTUAL FUND
  4. 2026-06-02BulkSELL · ₹643.9 CrJAYANTI SINHA
  5. 2026-06-02BlockBUY · ₹25 CrBNP PARIBAS ARBITRAGE - ODI
  6. 2026-06-02BlockBUY · ₹45 CrDSP MUTUAL FUND
  7. 2026-06-02BlockBUY · ₹25 CrEDELWEISS MUTUAL FUND
  8. 2026-06-02BlockBUY · ₹25 CrGOLDMAN SACHS BANK EUROPE SE
  9. 2026-06-02BlockBUY · ₹265 CrHDFC MUTUAL FUND
  10. 2026-06-02BlockBUY · ₹469.8 CrICICI PRUDENTIAL MUTUAL FUND
  11. 2026-06-02BlockSELL · ₹643.9 CrJAYANTI SINHA
  12. 2026-06-02BlockBUY · ₹25 CrMORGAN STANLEY ASIA SINGAPORE PTE
  13. 2026-06-02BlockBUY · ₹25 CrNIPPON INDIA MUTUAL FUND
  14. 2026-06-02BlockSELL · ₹286 CrSAMPRADA&NANHAMATI SINGH FAMILY TRUST
  15. 2026-06-02BlockBUY · ₹25 CrSOCIETE GENERALE
  16. 2026-06-01NewsAlkem Laboratories to open trading window on June 1, 2026scanx.trade
  17. 2026-05-31NewsEarnings Miss: Alkem Laboratories Limited Missed EPS By 8.9% And Analysts Are Revising Their Forecastssimplywall.st
  18. 2026-05-25NewsAlkem Laboratories schedules meeting with SBI Mutual Fundscanx.trade
  19. 2026-05-12NewsAlkem Laboratories stock (INE540L01014): Indian pharma leader near 52-week highsAD HOC NEWS
  20. 2026-04-24NewsAlkem Labs CEO Dr. Vikas Gupta resigns; stock falls nearly 3%BusinessLine
  21. 2026-02-13NewsAlkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Upsimplywall.st

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

Bulk & block deals

13 deals · 2026-06-02 → 2026-06-02

DateCounterpartyInvestor typeSideValue
2026-06-02ICICI PRUDENTIAL MUTUAL FUNDInstitutionBUY₹469.8 Cr
2026-06-02JAYANTI SINHAHNI / otherSELL₹643.9 Cr
2026-06-02BNP PARIBAS ARBITRAGE - ODIHNI / otherBUY₹25 Cr
2026-06-02DSP MUTUAL FUNDInstitutionBUY₹45 Cr
2026-06-02EDELWEISS MUTUAL FUNDInstitutionBUY₹25 Cr
2026-06-02GOLDMAN SACHS BANK EUROPE SEHNI / otherBUY₹25 Cr
2026-06-02HDFC MUTUAL FUNDInstitutionBUY₹265 Cr
2026-06-02ICICI PRUDENTIAL MUTUAL FUNDInstitutionBUY₹469.8 Cr
2026-06-02JAYANTI SINHAHNI / otherSELL₹643.9 Cr
2026-06-02MORGAN STANLEY ASIA SINGAPORE PTEHNI / otherBUY₹25 Cr

13 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

Results & transcripts

News & chatter on ALKEM

RSS News

6

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.